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ABST RACT
Lipomas, the most common type of benign tumours, are generally developed
from adipose tissue and present an incidence of 2.1 per 1000 inhabitants. In
addition to lipomas, at least three other maladies of the adipose tissue lead
patients to consult a doctor, especially for aesthetic purposes: multiple
familial lipomatosis, diffuse congenital lipomatosis, and adiposa doloris.
Unlike lipomas, these maladies are characterized by numerous lipomas,
encapsulated or not, of different sizes, symmetrical or not, which may appear
in the neck, limbs, or the trunk, sometimes being painful. The life quality of
these patients is affected, not only from an aesthetic point of view but also
from medical considerations, like pain. Chemical lipolysis has proven
unsatisfactory for patients due to several reasons: the prolonged therapy,
high cost, the partial dissolution of the lipomatosis, and high recurrence at
one year. Surgical treatment remains the only viable option; sometimes
when numerous lipomatous tumors required large and numerous incisions,
treatment was refused by patients. The result after laser liposuction is
excellent, the recovery time is short, without much pain for the patient, with
minimal ecchymoses and edemas, without any recurrence in time, and with
an excellent degree of patient satisfaction.

Introduction
Lipomas are the most common type of benign tumours
developed from adipose tissue. These are generally welllocated and of varying sizes, can appear at any age, in both
sexes, and can manifest in several clinical forms. Benign
adipose tumours can be classified into solitary lipomas,
multiple familial lipomatosis, and diffuse congenital
lipomatosis (benign symmetrical lipomatosis) [1].
Our practice has uncovered a number of cases of
patients, from subjects who presented for a single lipoma
(with clinical manifestations and/ or esthetic aspects) to
those who presented with multiple lipomas of different
sizes, sometimes more than 30 lipomas with or without
clinical manifestations.
Most often lipomas did not have clinical manifestations
but, even when these were present, the main reason for
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consultation with the doctor was an aesthetic purpose,
regardless of age. The main concern of these patients has
been “How will it look after we remove it? Will, there be
any scar?" Every surgeon is aware that the biological
process of scarring has particularities from one patient to
another, and that scarring is sometimes unpredictable as an
esthetic result. Thus, if patients presented with one or more
lipomas on areas of the body covered by clothing, they
more easily accepted the surgery. In contrast, when patients
presented with 10 or 20 lipomas, most on the upper limbs
or even in the cervical region, more discussion and
clarification with patients were needed. Usually, patients
wanted to remove lipomas because they were aesthetically
disturbing but, at the same time, they wanted the guarantee
that they would not leave unsightly scars.
In this clinical context, and taking into account the
psychological implications for the patient, we have tested
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a variety of solutions in the treatment of multiple lipomas.
The first therapeutic alternative was represented by
chemical lipolysis. It consists of directly injecting an
emulsifying substance into the adipose tissue, such as
phosphatidylcholine (PPC) and deoxycholic acid (DOC).
Injected active substances cause the slow progressive
dissolution of the fat cells, without leading to an increase
of triglycerides in the blood. The fat released is
subsequently metabolized by the liver. Usually, 2-4
treatments are necessary (at 4-8-week intervals) for the
procedure to be successful [2]. Treatments can also be
performed at shorter intervals, more precisely about two
weeks, in which case dose selection is essential. Each
session lasts about 30 minutes and should dissolve 1-3 cm
from the fat layer. In fact, the lipomas would not disappear
completely in most women, and treatment/ healing times
after each session were long, so that over time most
patients became less compliant at treatment; in addition,
we have noticed numerous recurrences, a finding
confirmed by other authors [2, 3]. The degree of patient
satisfaction, as well as our degree/ professional
appreciation, was sometimes low, so that we sought other
therapeutic options. The second alternative for us, as well
as for other authors [4], was surgical ablation through small
excisions. This solution was not very agreeable when the
location of the lipomas was in aesthetic/visible areas, and
in cases where the number of lipomas was very high, the
patients objected to multiple incisions.
Given these goals (to treat lipomas through minimal
scarring, in a short amount of time, and with a minimum
recovery period), we decided to purchase a NdYag 1064
laser, Deka SmartLipo, whose preset indication and work
schedule are specific to the treatment of lipomas. Since the
1980s, liposuction has been used in the treatment of
multiple familial lipomatosis [5]. Laser lipolysis has been
recently introduced in the treatment protocol for lipomas
therapy, and the indications, procedures, and the long-term
diagnosis/ outcomes are still under debate [6].

Discussions
The main difficulty/challenge is to understand exactly
what the patient wants, and how important the aesthetic
result is for him/her. Thus, before choosing the form of
treatment, it is useful (both for the patient and physician)
to identify the patient's wishes and expectations so as to
obtain a maximum degree of post-therapeutic satisfaction.
In this regard, we have developed a questionnaire that the
patient must complete before surgery and during medical
consultations.
Pre-treatment assessment questionnaire:
1. What is the main reason you want lipoma(s) removal?
- for esthetic purposes
- for medical purposes: localized pain
- prophylactic
purposes
(fear
of
transformation)

malignant

2. How important is the aesthetic result and a possible scar
for you?
- very important
- important
- little or no important
3. What is the time interval you could offer for treatment
and recovery?
- 1 week (for laser treatment)
- 2-4 weeks
- 1-3 months
4. What is your first treatment option?
- laser lipolysis
- chemical lipolysis
- surgical ablation
5. What is the main criterion in choosing the treatment?
- the cost of the treatment
- duration of the treatment and recovery period
- the esthetic result.
The second challenge was to establish indications and
contraindications for laser treatment. The NdYag laser may
be used for the following indications [7]:
- lipomas smaller than 5 cm, well-outlined, mobile, that
do not affect any nerve and that have not presented an
accelerated growth in the last months
- benign symmetrical lipomatosis (Madelung’s malady)
- diffuse familial lipomatosis
Relative contraindication:
- Dercum’s disease
Absolute contraindication:
- bulky lipomas with suspicion of liposarcoma
-

General contraindications of the laser for liposuction:
uncontrollable high blood pressure
cardiac failure
decompensated diabetes
pregnancy
mental disorders

We also needed to consider the potential for
malignancy, which is increased for lipomas over 5-6 cm
and, from this perspective, laser-assisted liposuction has
the disadvantage of not preserving tissue fragments for
biopsy. In such cases, we prefer surgical excision of the
large lipomas or, as a last resort, the classic liposuction
with the histopathological examination of the various
tissue fragments and, possibly, with the lipo laser.
Preoperatively, we recommend a minimal set of
laboratory tests and, for painful lipids or a location near a
nerve or vessel, soft tissue ultrasound is recommended.
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The treatment is performed under local anesthesia for
small lipomas, or intravenous sedation / general anesthesia
for large lipomas, numerous lipomas, or patients with a
history of panic attacks or phobias of different etiologies.
The procedure is relatively accessible. The anesthesia
is followed by the minimal infiltration of the lymphomas
with Klein solution [6], followed by a 2-3 mm incision
through which the lipo laser cannula is inserted. The
program is preset for lipids by the device, but can be
adjusted manually, depending on the size of the lipids and
the response to treatment. For lipomas larger than 1 cm,
classical liposuction can be combined with laser lipolysis.
The working technique:
For liposuction, small cannulas 3-4 cm thick were used,
with a single minimal incision. For laser lipolysis, a 300
µm fiber, with 6-8 W power and 3,000-6,000 J energy was
used for a single lipoma depending on its size. The
advantages of NdYag laser therapy are:
- a single session is usually necessary
- the recovery period is minimal, i.e., 2-4 days, with
reduced discomfort
- it can also be performed with a local anaesthesia
- all lipomas can be treated in a single session
- it can concomitantly perform a skin tightening, so that
for superficial and medium-sized lipomas the excision
of the skin was not necessary
- in most cases no local skin bruising occur
- the aesthetic appearance is remarkable and often a 19G
needle is sufficient (instead of making a minimal
incision), while healing should not leave scars. The
incisions are closed with intradermal 5.0 absorbable
threads
After the procedure, patients are daily monitored, and
prophylactic antibiotic therapy could be administered
(Augmentin or Oxacylin of 500 mg for 5-7 days);
painkillers and anti-inflammatory drugs (Paracetamol,
Tador, Doreta) are also administered, and in case of small
ecchymoses, arnica-based solutions (Arnigel) are
administered as well. For the prevention of unaesthetic
scars, Contractubex or Stratamed can be applied for three
months after the intervention.
The results obtained with Deka SmartLipo laser are
generally very good. In addition to all the advantages
mentioned above, patients are aesthetically satisfied, an
important aspect because most patients present
themselves to the doctor with concern about the aesthetic
aspects of the lipomas.
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After treatment, the patient should evaluate his/her
degree of satisfaction:
1. Are you satisfied with the treatment administered?
2.

very satisfied (3 points)
satisfied (2 points)
unsatisfied (1 point)
Are you satisfied with the final esthetic result?

3.

very satisfied (3 points)
satisfied (2 points)
unsatisfied (1 point)
How much has your quality of life improved?

-

very much (4 points)
satisfactorily (3 points)
a little (2 points)
very little (1 point)
Based on this form, the patient's degree of satisfaction
after the laser-assisted liposuction can be established:
• 9-10 points – an excellent result, a high degree of
satisfaction
• 7-8 points – very good result, a good degree of
satisfaction
• Under 7 points – the average result, low degree of
satisfaction
The lipoma is a benign affliction, with an incidence of
2.1 per 1000 persons. The location of these lipomas can
sometimes be atypical. They may be encountered in
various areas, such as at the level of the scrotum; when
lipomas present low consistency they can be confused with
external hernias [8]. In the case of development of
lipomatous masses within the mediastinum, the differential
diagnosis must be made with tumours or even with
diaphragmatic hernias. Other possible differential
diagnoses are with neurofibromas, schwannomas, synovial
cysts, etc., depending on location [9, 10]. The treatment of
solitary lipomas is usually surgical, but the laser lip may be
considered, depending on the location, size, and preference
of the patient. For lipomas larger than 5 cm and with rapid
growth, the only safe therapeutic approach remains
surgical ablation, with a histopathological examination to
exclude possible liposarcoma.
Multiple familial lipomatosis was first described in
1970 by Das Gupta as a benign affliction characterized by
the occurrence of numerous encapsulated lipomas [11],
unlike diffuse congenital lipomatosis in which the lipomas
are not encapsulated. The angiolipoma differentiates from
the lipoma through the presence of capillary proliferation
and slight fibrosis of the connective tissue. The incidence
of multiple familial lipomatosis is approximately 0.002%,
being rarely encountered. It is a disease with
predominantly autosomal dominant transmission, although
cases of recessive autosomal transmission have also been
reported [12]. Lipomatosis can also be associated with
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Madelung’s disease, Gardner’s syndrome (a hereditary
disease characterized by the presence of multiple polyps in
the colon, in association with bone tumours and soft tissue
tumours), or Dercum’s disease (painful adiposity, which
mainly affects women at menopause) [13]. Even if they
are frequently associated with polyneuropathy, the
relationship between these maladies is still under
discussion, the main causative factor being represented by
the cytopathy of the mitochondria and the disorders of the
lipid metabolism [14].
Benign symmetrical lipomatosis is characterized by the
presence of some adipose masses of large dimensions,
slightly circumscribed, of soft consistency, painless, nonencapsulated, usually located at the cervical level and the
extremities. The lipomatous masses develop in the
subcutaneous cellular tissue and frequently infiltrate the
adjacent planes. The disease generally affects men between
30-60 years old, the men/women ratio ranging between
15/1 and 30/1, the most extensive spread being recorded in
Mediterranean countries [15]. Benign symmetrical
lipomatosis can occur sporadically, or it may be familial
(with dominant, autosomal transmission). The incidence of
the disease is 1 to 250,000 [16]. It is also known as
Madelung’s
disease,
Launois-Bensaude’s
adenolipomatosis, Brodie’s syndrome, or Buschke’s disease. The
disease is frequently associated with alcohol consumption,
over 90% of the patients being chronic alcohol users [17]
and with polyneuropathy [18]. More than two-thirds of the
patients are overweight, which is also an aggravating factor
of the disease, accelerating the development of lipomatous
masses [16].
From a clinical perspective, two types have been
described. Type I, in which lipomas are located in the
cervical region and the supraclavicular and deltoid regions
(with the occurrence of the so-called “bull-neck”/
Madelung’s collar), sometimes with the invasion of the
mediastinum manifested through the feeling of suffocation
of the patient as a result of the tracheal compression. Type
II, in which lipomas are located throughout the body,
except for the neck, giving the impression of ordinary
obesity without profound involvement. The possibility of
malignant transformations is exceptional, although some
cases of malignancy of familial symmetrical lipomatosis
have been reported. The diagnosis of symmetrical
lipomatosis is based on the symmetrical distribution of fat
deposits and on the fact that the arms and the legs do not
exhibit areas of lipodystrophy [19-21]. The leading causes
for the occurrence of this malady could be represented by
an enzymatic defect or an alteration of the membranous
receptors (which would lead to a decrease in adrenergic
lipolysis), or sympathetic denervation of brown adipocytes
(which would lead to hypertrophy and mitochondrial DNA
mutations) [22, 23]. It can be associated with different
metabolic disorders: insulin resistance, hyperuricemia,

renal tubular acidosis, the increase of hepatic enzymes
(cytolysis, cholestasis), disorders of the thyroid gland, of
the adrenal glands, of the hypophysis. Paradoxically, there
is an increase in high-density lipoproteins (HDL) [24-26].
Liposuction seems to be the best treatment option for those
that are superficially located, although it cannot prevent
recurrences [27, 28]. The prognosis mainly depends on the
concomitance of neuropathy which may significantly
increase mortality [16].
Dercum’s disease, also called adiposis dolorosa or
neurolipomatosis, is an unusually progressive disease of
unknown etiology, characterized by the occurrence of
some multiple lipomas, encapsulated or not, painful, which
frequently occur in overweight women at menopause. The
onset is insidious. The pain is due to the compression of the
lipomas on the nerves, being described by the patients as
“the fat that hurts”. Its hereditary transmission is
dominantly autosomal, from mother to daughter [29-31].
The mechanisms of the disease are still unknown, and the
origin of the pain remains uncertain. The histopathological
exam does not show any differences between these
tumours and the regular lipomas. The diagnostic criteria for
neurolipomatosis comprise the four cardinal symptoms:
multiple and painful fat masses; generalized obesity
especially at menopause; asthenia, weakness, and fatigue;
and mental changes with emotional instability, depression,
confusion, and dementia. The conditions associated with
adiposis dolorosa include sleep disturbances, irritable
bowel, carpal tunnel syndrome, Tietze syndrome, thyroid
dysfunction, tendonitis and myalgia [32-35].
Three clinical types of Dercum’s disease have been
described:
• type I, the juxta-articular type, with folds or painful fat
in the knees and the thighs
• type II, diffuse/ generalized, with the extension of the
pain
• type III, the nodular type, with intense pain in and
around the multiple lipomas attached to the adjacent
tissue.
The diagnosis is difficult to make, because there are no
specific signs or symptoms, and even the histopathological
examination cannot provide a diagnosis of certainty.
Differential diagnosis must be made with progressive
lipodystrophy,
Proteus
syndrome,
fibromyalgia,
myasthenia
gravis,
Madelung’s
syndrome,
neurofibromatosis, and Cushing’s syndrome [36, 37].
Moreover, associated pathologies at the dermal-epidermal
level can overlap the lipomas [38-40].
No treatment can alter the course of the disease, and
those available are symptomatic only. The use of systemic
corticosteroids, intravenous anesthetics, and analgesics are
indicated. Liposuction produces a significant improvement
19
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of the pain and the quality of life with the mention that the
lowest laser energies should be used since lipomas are
often connected to nerves that should be protected from
heat emitted by the laser, this aspect generating thus
distinct options (the relative indication or contraindication)
of the lipo laser for this sickness [41, 42].

Highlights
✓ Lipomatosis has a relatively rare incidence, is well
localized and occurs at any age in both sexes in
patients with congenital or familial lipomatosis.
✓ Taking into account the psychological implications for
the patient we have always tried alternative solutions
in the treatment of multiple lipomas, and laser therapy
with NDYAG 1064 NM LASER seems to be an
optimal choice.

Conclusions
Although multiple lipomatosis is relatively rare, its
treatment option is still challenging because most patients
present to the doctor for an aesthetic purpose. Chemical
lipolysis proved to have poor results, with a long period of
treatment and high costs for the patient, so we no longer
consider it a feasible therapeutic alternative. Surgical
excision is often refused by patients, even if it involves
minimal incisions, mainly due to the numerous resulting
postoperative scars, whose evolution is often
unpredictable. In this context, we consider that laser
liposuction would be the optimal treatment for these
maladies, with mention that patients must be well
examined preoperatively. When lipomas are large or
painful, the ultrasound of soft parts is also necessary to
specify the anatomical relationships with the surrounding
tissues. There were no recurrences in the studied group
until the date of publication of this paper.
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